The prognostic role of cardiopulmonary exercise testing in obesity.

IF 5.4 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Audrey Borghi-Silva, Baruch Vainshelboim, Cássia da Luz Goulart, Ross Arena, Jonathan Myers
{"title":"The prognostic role of cardiopulmonary exercise testing in obesity.","authors":"Audrey Borghi-Silva, Baruch Vainshelboim, Cássia da Luz Goulart, Ross Arena, Jonathan Myers","doi":"10.1111/dom.15877","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Poor cardiorespiratory fitness has been suggested to increase the risk of chronic diseases in obesity. We investigated the ability of key variables from cardiopulmonary exercise testing (CPET) to predict all-cause mortality in an obese cohort.</p><p><strong>Methods: </strong>The sample included 469 participants of both sexes (mean age 40 ± 13 years) who underwent a CPET for clinical reasons between 1 March 2009 and 1 December 2023. All-cause mortality was the prognostic endpoint. A receiver operating characteristic analysis was performed to establish optimal cut-points for CPET variables. Kaplan-Meier and Cox regression analyses were used to determine the association between CPET variables and all-cause mortality.</p><p><strong>Results: </strong>There were 46 deaths during a mean follow-up period of 69 ± 48 months, resulting in an annual mortality rate of 2%. Despite the sample being made up of mostly women (70%), there were more deaths in men (18 vs. 6%, p < 0.001).The optimal thresholds for discrimination of survival were as follows: (a) peak oxygen uptake (pVO<sub>2</sub>) ≤16 mL/kg/min; (b) minute ventilation/carbon dioxide production (V<sub>E</sub>/VCO<sub>2</sub>) slope ≥31; (c) ventilatory power ≤5.8 mmHg; and (d) circulatory power ≤2980 mmHg/mL O<sub>2</sub>/min. Kaplan-Meier survival plots revealed a significant positive association between lower pVO<sub>2</sub>, circulatory power and ventilatory power values and survival (log-rank, p < 0.001) and higher mortality for men than women. Adjusted Cox regression models showed that a pVO<sub>2</sub> ≤16 mL/kg/min had a 20-fold higher risk of mortality when compared with >16 mL/kg/min.</p><p><strong>Conclusion: </strong>Given the strong association of VO<sub>2</sub>, ventilatory efficiency, circulatory and ventilatory power with all-cause mortality, our findings support the notion that poorer cardiorespiratory fitness is associated with a poor prognosis in patients with obesity.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":null,"pages":null},"PeriodicalIF":5.4000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.15877","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Poor cardiorespiratory fitness has been suggested to increase the risk of chronic diseases in obesity. We investigated the ability of key variables from cardiopulmonary exercise testing (CPET) to predict all-cause mortality in an obese cohort.

Methods: The sample included 469 participants of both sexes (mean age 40 ± 13 years) who underwent a CPET for clinical reasons between 1 March 2009 and 1 December 2023. All-cause mortality was the prognostic endpoint. A receiver operating characteristic analysis was performed to establish optimal cut-points for CPET variables. Kaplan-Meier and Cox regression analyses were used to determine the association between CPET variables and all-cause mortality.

Results: There were 46 deaths during a mean follow-up period of 69 ± 48 months, resulting in an annual mortality rate of 2%. Despite the sample being made up of mostly women (70%), there were more deaths in men (18 vs. 6%, p < 0.001).The optimal thresholds for discrimination of survival were as follows: (a) peak oxygen uptake (pVO2) ≤16 mL/kg/min; (b) minute ventilation/carbon dioxide production (VE/VCO2) slope ≥31; (c) ventilatory power ≤5.8 mmHg; and (d) circulatory power ≤2980 mmHg/mL O2/min. Kaplan-Meier survival plots revealed a significant positive association between lower pVO2, circulatory power and ventilatory power values and survival (log-rank, p < 0.001) and higher mortality for men than women. Adjusted Cox regression models showed that a pVO2 ≤16 mL/kg/min had a 20-fold higher risk of mortality when compared with >16 mL/kg/min.

Conclusion: Given the strong association of VO2, ventilatory efficiency, circulatory and ventilatory power with all-cause mortality, our findings support the notion that poorer cardiorespiratory fitness is associated with a poor prognosis in patients with obesity.

心肺运动测试对肥胖症的预后作用。
目的:心肺功能不佳被认为会增加肥胖症患者罹患慢性疾病的风险。我们研究了心肺运动测试(CPET)的关键变量预测肥胖人群全因死亡率的能力:样本包括 2009 年 3 月 1 日至 2023 年 12 月 1 日期间因临床原因接受 CPET 测试的 469 名男女参与者(平均年龄为 40 ± 13 岁)。全因死亡率是预后终点。为确定 CPET 变量的最佳切点,进行了接收者操作特征分析。采用 Kaplan-Meier 和 Cox 回归分析确定 CPET 变量与全因死亡率之间的关系:在平均 69 ± 48 个月的随访期间,共有 46 人死亡,年死亡率为 2%。尽管样本中女性居多(70%),但男性死亡人数较多(18 对 6%,P 2):(a)通气量≤16 mL/kg/min;(b)分钟通气量/二氧化碳产生量(VE/VCO2)斜率≥31;(c)通气能力≤5.8 mmHg;(d)循环能力≤2980 mmHg/mL O2/min。Kaplan-Meier 生存图显示,较低的 pVO2、循环功率和通气功率值与生存之间存在显著的正相关(log-rank,p 2 ≤16 mL/kg/min 与 >16 mL/kg/min 相比,死亡风险高出 20 倍):鉴于容氧量、通气效率、循环和通气功率与全因死亡率密切相关,我们的研究结果支持了心肺功能较差与肥胖症患者预后不良有关的观点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信